US Broker Ratings

Danaher Corporation (DHR) Stock Analysis: Unveiling a 35.50% Upside Potential Amidst Robust Analyst Support

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) represents a compelling investment option. With a market capitalization of $138.25 billion, Danaher is a heavyweight..

HCA Healthcare (HCA) Stock Analysis: Evaluating Growth in a Competitive Healthcare Sector

Investors eyeing the healthcare sector for stable and potentially lucrative opportunities may find HCA Healthcare, Inc. (NYSE: HCA) a compelling case study. With a market capitalization of $119.15 billion, HCA..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Analyst Consensus Points to a 35% Upside

For investors eyeing the healthcare sector, IQVIA Holdings, Inc. (NYSE: IQV) stands out as a formidable player within the diagnostics and research industry. Based in Durham, North Carolina, IQVIA offers..

ResMed Inc. (RMD) Stock Analysis: Navigating the Healthcare Sector with a 17.64% Upside Potential

ResMed Inc. (RMD), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a market capitalization of $36.91 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Unpacking a 24% Potential Upside with Diagnostic Precision

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $24.71 billion, this Swiss-based..

Sanofi (SNY) Stock Analysis: Exploring a Potential 29.47% Upside in the Healthcare Giant

Sanofi (SNY), a leading player in the healthcare sector, is capturing investor attention with a promising potential upside of 29.47%. With a market capitalization of $107.59 billion, this Paris-based pharmaceutical..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 14% Upside Potential

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, has caught the attention of investors with its robust market presence and potential for significant upside. As a leader..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 46.10% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, stands out with a striking potential upside of 46.10%, capturing investor attention. With its market cap soaring at..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.55% Potential Upside in the Medical Device Sector

Stryker Corporation (SYK), a prominent player in the healthcare sector, primarily focuses on medical devices. With a market capitalization of $139.51 billion, Stryker stands as a formidable force in the..

Eli Lilly and Company (LLY) Stock Analysis: Unveiling a 22.62% Potential Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture the attention of investors with its promising growth prospects and significant market presence. With a..

Merck & Company (MRK) Stock Analysis: Strong Growth Potential with a 9.87% Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the global healthcare sector, with its roots deeply entrenched in the drug manufacturing industry. As of its latest..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a 25% Upside in the Healthcare Sector

Novo Nordisk A/S (NVO), a stalwart in the healthcare sector, holds a commanding presence in the drug manufacturing industry with a focus on diabetes and obesity care, as well as..

Prothena Corporation plc (PRTA) Stock Analysis: Eyeing a 116.70% Upside with Promising Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, is attracting significant attention from investors due to its robust late-stage clinical pipeline and potential for substantial upside...

AngioDynamics, Inc. (ANGO) Stock Analysis: A 77.86% Potential Upside in Healthcare’s Innovative Frontier

AngioDynamics, Inc. (NASDAQ: ANGO), a leading player in the healthcare sector specializing in medical instruments and supplies, offers a tantalizing opportunity for investors with a potential upside of 77.86%. With..

Emergent BioSolutions Inc. (EBS): Analyst Ratings Signal Nearly 60% Upside Potential

Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly those focused on the healthcare sector. Specializing in preparedness and response solutions for various public health threats, Emergent..

Cel-Sci Corporation (CVM): Investor Outlook on Potential 962.50% Upside in Biotechnology Sector

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company with a market capitalization of $33.83 million, is capturing investor attention with a staggering potential upside of 962.50%. Operating in the healthcare..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a Potential 45.53% Upside in the Biotechnology Sector

Fortrea Holdings Inc. (FTRE), a promising player in the biotechnology industry, presents a compelling opportunity for investors searching for growth in the healthcare sector. With its headquarters in Durham, North..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 53% Upside Potential Amid Strong Buy Ratings

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has emerged as a captivating story in the biotechnology sector, offering investors a promising opportunity with a potential upside of 53.29%. This clinical-stage biopharmaceutical company,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a Promising 72.76% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with a remarkable potential upside of 72.76%. Positioned in the dynamic biotechnology industry within the healthcare sector, this Boston-based..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Can This Medical Device Innovator Rebound with a 176.98% Potential Upside?

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a promising player in the healthcare sector specializing in medical devices, has recently captured investor attention due to its substantial potential upside. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds